Esther Hinojosa - Publications

Evaluation of Genetic Variants Associated with the Risk of Thiopurine-Related Pancreatitis: A Case Control Study from ENEIDA Registry.

Journal: Digestive diseases (Basel, Switzerland)

Published: September 13, 2023

Risk Factors for COVID-19 in Inflammatory Bowel Disease: A National, ENEIDA-Based Case-Control Study (COVID-19-EII).

Journal: Journal of clinical medicine

Published: September 18, 2022

Long-Term Outcomes of Biological Therapy in Crohn's Disease Complicated With Internal Fistulizing Disease: BIOSCOPE Study From GETECCU.

Journal: The American journal of gastroenterology

Published: July 11, 2022

Using Interpretable Machine Learning to Identify Baseline Predictive Factors of Remission and Drug Durability in Crohn's Disease Patients on Ustekinumab.

Journal: Journal of clinical medicine

Published: June 10, 2022

Ferric Carboxymaltose Improves the Quality of Life of Patients with Inflammatory Bowel Disease and Iron Deficiency without Anaemia.

Journal: Journal of clinical medicine

Published: April 21, 2022

Ustekinumab and vedolizumab for the prevention of postoperative recurrence of Crohn's disease: Results from the ENEIDA registry.

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Published: April 06, 2022

Nationwide COVID-19-EII Study: Incidence, Environmental Risk Factors and Long-Term Follow-Up of Patients with Inflammatory Bowel Disease and COVID-19 of the ENEIDA Registry.

Journal: Journal of clinical medicine

Published: December 09, 2021

Immigrant IBD Patients in Spain Are Younger, Have More Extraintestinal Manifestations and Use More Biologics Than Native Patients.

Journal: Frontiers in medicine

Published: November 28, 2021

Long-Term Real-World Effectiveness and Safety of Ustekinumab in Crohn's Disease Patients: The SUSTAIN Study.

Journal: Inflammatory bowel diseases

Published: September 10, 2021

Effectiveness and Safety of Ustekinumab in Ulcerative Colitis: Real-world Evidence from the ENEIDA Registry.

Journal: Journal of Crohn's & colitis

Published: April 16, 2021

Clinical Characteristics, Associated Malignancies and Management of Primary Sclerosing Cholangitis in Inflammatory Bowel Disease Patients: A Multicentre Retrospective Cohort Study.

Journal: Journal of Crohn's & colitis

Published: May 08, 2019

Validation of a population pharmacokinetic model of adalimumab in a cohort of patients with inflammatory bowel disease.

Journal: Revista espanola de enfermedades digestivas

Published: April 26, 2019